"Gastritis"
should not be a nasty word, yet it has become one. It is a word that often seems mysterious, a word with too many conflicting meanings, each of which is dependent on who defines it. For the patient gastritis conjures up images of acute epigastric peptic ulcer-type pain, sometimes accompanied by nausea and vomiting, perhaps after an episode of overindulgence with food and drink. Other patients' gastritis accounts for their constant low grade upper abdominal gnawing pain that only temporarily goes away with overthe-counter antacids and then comes back. There is endoscopic gastritis, the erythematous, edematous, friable, slightly eroded mucosa found in stomachs of patients who have the symptoms referred to above and, peculiarly, also in the stomachs of those who are asymptomatic.
Finally, for the pathologist gastritis is an annoying collection of pits, glands, acute and chronic forms of inflammation, metaplasias, and bacteria, and these, in any combination or in no combination at all, may or may not have anything to do with the gastritis of. the patient and the gastritis of the endoscopist.'-" To be perfectly frank the correlation between histological and endoscopic gastritis is terrible! When the endoscopist sees spectacular inflammatory changes, even with erosions, a biopsy specimen of such an area, even of an erosion, is almost as likely to be normal as inflamed."," Whatever it is that the endoscopists see often has no histological counterpart. Furthermore, a biopsy specimen from an endoscopically normal antrum may be intensely and actively inflamed. In contrast, the endoscopic histological correlation for lumps, masses, or big ulcers is very good. No wonder there have been a bewildering number of classifications of gastritis, some of which attempt to relate endoscopic and histological alterations as well as others that make no pretense at correlation.
Some classifications are named after people, such as Whitehead, whereas others are named after cities, such as Sidney.'.' Some use letters to designate types of gastritis, giving us types A. B, AB, and C to play with, whereas others skip letters and use words instead."," It is also no wonder that any clinical classification of gastritis is likely to be of little value, considering the lack of correlation between symptoms, endoscopic findings, and histological features.
Nevertheless, we pathologists must contend with gastric inflammatory disease, much as we must deal with inflammations of the esophagus and colon. Our clinical colleagues continue to perform biopsies on stomachs, hoping that we will offer them some help with their patients who have unpleasant upper gut symptoms or striking endoscopic findings. To begin, we have to demystify the word gastritis. This is best accomplished by developing a classification system that is simple and easily applicable to the types of inflammations that we see regularly in our gastric biopsy specimens.
In the past 6 years several classifications for gastritis have appeared in independent articles, chapters in books, and gastrointestinal pathology texts ( Table 1 ). All of them include the common gastritides, although the names vary.!'-"L Furthermore, much of the descriptive work in histological gastritis is still being published and, in addition, it is critical that a classification scheme recognize that there are inflammations that do not fit into predetermined categories; in other words, there are gastritides that have not yet been named. Therefore, any classification system must allow for periodic revisions. Such a system also should recognize that more than one type of gastritis will occasionally occur in stomachs, so that there may be double or triple gdstritides.
We have known for years that there are acute gastric injuries and inflammations that include small super- Sometimes, these injuries lead to extensive superficial mucosal necrosis accompanied by hemorrhage. These reactions are the acute types of gastritis, and they have been given names like "acute erosive gastritis" or "acute hemorrhage gastritis." Precipitating injuries include alcohol, steroids, .aspirin, and other non-steroidal anti-inflammatory drugs (NSAIDs). Such acute processes have not been part of the gastritis mystery unless theywere superimposed ton a chronic inflammation.
These will be discussed in more detail below.
It is the variety of inflammations with overtones of chronicity that is the problem. In the past it was assumed that chronic gastritis was a single disease with a collectioir of-histological characteristics that were presc'nt in various combinations.
Different forms of chronic gastritis differed only in the intensities of these histological characteristics and in their mix.' Furthermore, the stomach was looked on as a single organ: yet we know that thcrr arc several distinctive mucosae, as different Irom each other as the mucosa of the small intestine differs from that of' the colon. This approach was aided by the fact that no studies identified a precursor lesion and svstematically followed it with sequential biopsies through intermediate stages to the full-blown end-stage chronic gastritis. As a matter of fact. this giant hole in our knowledge and understanding persists because we still have no proof of how each chronic gastritis evolves and what the precursor or precursors are. A frequent suggestion implicates a ubiquitous mild inflammation known simply as "superficial gastritis" as the common precursor. hut there is no proven support for that contention, Ionlv some questionable evidence based on population stuciies.'~"~" However, this should not deter us. M'c also havcb no idea of the histological evolution of most otl1c.r chronic inflammations of the gut, including ulcerative colitis. collagenous colitis, and Crohn's disease. Recent discoveries, aided by the intense use of upper endoscopy and the frequent biopsy specimens obtained by our endoscopic colleagues. have given ~1s insights into the intricacies of the chronic gastritides. We now recognize that several separate chronic entities exist, although new discoveries seem to relate some of' them. Unfortunately, the more we know about the chronic gastritides, the more names we invent for the same diseases. The practicing pathologist must choose which names he or she will use routinely, and that pathologist must ensure that the endoscopists understand what the names mean. It is silly to adopt a nomenclature that has no meaning for the very people on whose business we depend for our livelihood! The following discussion is based on a simple, functional classification of gastritis, concentrating mostly on the chronic fijrms, that has proven useful in a busy endoscopic biopsy practice in a large teaching hospital (Table 2) . It incorporates many attributes of other classifications, hopefully the hest ones, and thus is not a fancifi4 invention of the author. In fact, it is really a simplified version of the classifications proposed by Correa and Yardley.","' It affirms the existence of several distinct entities, but it offers several choices of names for most entities, recognizing that dif- This classification system can be used easily when more than one type of gastritis occurs in a single stomach, each of which may have an independent cause or epidemiological association. The following discussion analyzes each item, not necessarily in its order in the It was well known that duodenal peptic ulcers were almost always accompanied by a significant chronic gastritis that involved the antral mucosa.21'" Furthermore, this gastril.is was characterized by three components:
( 1) diffuse plasmacytosis of the superficial mucosa, (2) Iymphoid nodllles deep in the mucosa, and (3) neutrophils invading the proliferative zone of the mucosa, the neck Iregion (Figs 1B to lD) .".')') In addition, pit hyperplasia in which the pits were longer than normal and often mucin-depleted was common. This complex was called "hypersecretory gastritis" by,Correa." It also involved the body mLlCOS& especially if the ulcers were in the stomach instead of the duodenum.
In such cases the gastritis occurred proximally to the ulcer as well as in the antrum so that the more proximal the ulcer, the more extensive the gastritis.',"
It even can involve the cardia that has a mucosa much like antral. Subseqtlently, this gastritis has been given several different names, including "diffuse antral gastritis," "type B chronic gastritis." "chronic active gastritis," and "chronic nonspecific gastritis."",","
The: lymphoid nodules and the plasma cells are probably the result of chronic antigenic stimulation by the organisms. Genta et al"" found that all individuals with Hpyloti infection, with or without gastric 01 duodenal ulcers, had lvmphoid nodules that were more common in the antrum than in the bodv, on the lesser rather than the greater curvature, and in ulcer patients rather than in those without ulcers. Treatment of the H j?lllori infection resulted in gradual shrinkage of the nodules. It has been our experience that the density of the plasma cells also diminishes and there is gradual loss of those plasma cells deep in the mucosa.'"
The organisms are found on the surface epithelial cells and less commonly on the superficial foveolar cells. In both locations they lie beneath the muco~ls coat, mostlv over intercellular junctions. They appear as slightly curved short rods. Ultrastructurally thev have four flagella at one pole. In almost all cases the brganihms are visible with hematoxylin-eosin (HE). The (iiernsa stain will darken them and silver stains, such as the W'arthin-Starry, will both darken and thicken them (Fig 1) . A. tissue &am stain also will make them more obvious. If all else fails there are commerciallv available antibodies for immunohistochemical de&on. How fhstidious a pathologist should be in looking for H&hi is a matter of' individual choice. Our approach has been to use HE only because it has been our experience that a careful search of the HE-stained slide will detect bacteria in almost every case; special stains add little, perhaps increasing the Yield by no more than 1%. If the gastritis is totally typical and if we cannot find the bacteria, then we use the Warthin-Starry stain. This situation occllrs less than once a month, and we resort to the special stain mostly out of f-rustration at not finding the bugs in the expected setting. Usually, the WarthinStarry stain is also negative in these cases. In contrast, some studies have reported a significant infection rate in patients with normal antral biopsy specimens using the specinl stains or culture or both."' We have no idea what it means to have H p$ori with no disease, but perhaps it indicates first infektion or a nonpathogenic strain. In addition. pressures from outside the pathol-0~ department may dictate the intensity with which wt. look for .Hpvlori. The gastroenterologists with whom we work mav feel it is important for them to know whether H @!cJ~? ii; present or absent in every gastric biopsy speciThe neutrophils generally invade epithelium that is mid-zone in the mucosa, at the level of the necks, whereas the infection is colonizing the surface and SW perficial pits. This fact is repeatedly-illustrated in essentially every publication in which there is a microscopic picture. The epithelium covered by the organisms is never inflamed, whereas inflamed epithelium is never covered by organisms. This discrepancy in location between bacteria and neutrophils has not been adequatcl) explained.
Soluble chemotactic factors, either released by the bacteria or by their interactions with host tissues, have been suspected. In patients infected with H p$ori tumor necrosis factor [TNF]-alpha production bv antral mucosa was higher when there was active gastriiis than when the gastritis was inactive.'" Tumor necrosis factoralpha can activate neutrophils.
Other neutrophilic chemotactic factors have been identified that appear to come from the bacterium itself.'7.'x There are modifications of the typical changes. For instance, the plasmacytosis may be accompanied by lymphocytosis and even ?.eosinophils, althongh when the) ale present the possibility of a second insult might be considered.
The infiltrate in the lamina propria also commonly extends into the glandular compartment fol unpredictable distances, sometimes reaching the mnscularis mucosae. Perhaps this deep extension is an index of severity. The combination of a deeply extending or transmucosal infiltrate plus deep lymphoid nodules results in a histological lesion in which the glands arc either spread apart or else are destroyed bv the inflammation:
in other words, there is loss of glands 01 atrophv. Unfortunately, we do not know which of these is the correct interpretation.
It' this is indeed destruction of glands then we should have identified a glanddestructive phase of the inflammation, yet such a phase has not been found. The active epithelial damage with neutrophils involves the necks. Because this is the generative zone of the gastric mucosa from which both pits and glands arisr, it is possible that darnnge to this zone results in selective loss of regenerative capabilities for the glandular compartment.
If such is the case then gland loss may be attributed to attrition without replaccment.
H&cohmrtu?-infection also has been reported to be associated with damage to the colonized surface and foveolar cpithelial cells in patients with both duodenal and gastric peptic ulcers or with the tvpical active chronic gastritis without ulcers.-"'."" Thc,se changes in-elude irregularities of the apical cytoplasm with indistinct cell borders and loss of apical mucin in almost all cases. Collections of such cells with loss of apical cytoplasm produce surface mucosal depressions or pits. How such changes relate to the ulcers is not clear because many of the ulcers are in the duodenum.
The evolution of the typical chronic and active diffuse antral gastritis that results from H pyloti infection is not known. As with other forms of chronic gastritis, a superficial inflammatory phase has been postulated in which the superficial mucosa, that part including the pits and necks and surrounding lamina propria but not the glands, contains excess plasma cells and/or lymphocytes. Supposedly, this reaction extends deeper into the mucosa and at some point the lymphoid nodules develop, but this theory has no proof. The acute infection, such as the one Marshall gave himself, may evolve into the typical chronic gastritis if the bacteria are not eradicated or cleared.g'
Helicobncter pylori is a strange gastroenteric organism. It does not like stagnant stomachs, but it seems to prefer those stomachs in which there is normal motility. In a study of gastroparesis, that is, stomachs with slow emptying, H pylori was rarely found compared with stomachs that emptied normally.?" It does not seem to thrive in less acidic environments, such as in bile reflux. In one study 83% of patients with peptic ulcers had H pylori before gastric operations, mostly partial gastrectomies. After the operations that led to bile reflux the infection rate decreased to 54%, but after Roux-en-Y biliary diversion that prevented bile reflux the infection rate increased to 920/o."' Is H pylon infection and its resultant gastritis a cause of symptoms, such as nonulcer dyspepsia? The data are conflicting.
In one study published before much was known about H pylon', active inflammation, that is, neutrophils, in biopsy specimens of either gastric body, antrum, or duodenum was more likely to be found in dyspeptic compared with nondyspeptic patients." In another study published after H pyloti was a well-known pathogen, nonulcer dyspepsia, whether associated with H pylori gastritis or with no histological inflammation and no bacteria, responded equally to a regimen directed at eradication of the organism." In still a third study of patients with nonulcer dyspepsia who were infected with H pvlori, specific treatment directed against the organism eradicated it and improved the associated gastritis but was not significantly better than placebo in improving symptoms."'
Helicobncter pylori colonizes metaplastic gastric surface cells in the duodenum, and this rnav be important if it is a cause of duodenal peptic ulcer."' However, the exact mechanism by which H pylon' infection leads to duodenal ulcers is not established. Nevertheless, the association is clear. Close to 1OOYo of patients with duodenal peptic ulcers have H pylon' and its gastritis in the antrum. Eradication of the organism dramatically reduces ulcer recurrence.
Why only a tiny fraction of individuals with this incredibly common infection develop peptic ulcers is not known, but rrhaps it is related to specific strains of the organism:"
Hdirobnrterp$oti also colonizes gastric type surface epithelial cells almost anywhere else. Infection has been reported in Barrett's mucosa and in ectopic gastric mucosa in Meckel's diverticula and in the rectum.'".'" When Barrett's epithelium is infected the gastric mucosa is always infected as well, suggesting that the Barrett's epithelium became colonized as a result of reflux. The status of the gastric mucosa in the Meckel's cases was not known, but in a report of H pylon' in ectopic gastric mucosa in the rectum the stomach also was infected.'* The role of Hpylori in atrophic gastritis and intestinal metaplasia has been studied in several diverse environments. Data are accumulating rapidly regarding the associations of Hpylori with carcinoma of the stomach."" It has been shown that the risk of gastric carcinoma is increased in populations with high infection prevalences, and this relationship is almost linear."" This ma) explain, at least in part, the high incidence of gastric cancer in Japan where H pvloti infection seems to be unusually common in olderadults.
Scores of published studies are appearing monthly linking H pvlori with gastric cancer, and possibly with certain histological types, but this may depend on the country in which the cancers were studied. For instance, in a study from Japan culture-proven H pylori infection occurred in 79% of patients with differentiated, or tubule-forming, early gastric carcinomas but only in 29% of patients with undifferentiated, including signet ring cell. early carcinomas."" In another studv from the United States H pyloriwas found in nonmalignant gastric mucosa in 890/o of patients with tubule-forming carcinomas but in onl) 32% of patients with diffLlse carcinomas."' Furthermore, it appears that Hpvlori is associated with noncardisc carcinomas rather than with those that arise in the cardia.'" In contrast, in a study from Singapore there was no difference in the rates of histological H pylon' infection between patients with tubule-forming and-diffuse carcinomas."" Similar results were reported from Finland where there was no difference in frequency of antibodies to Hpvlori and in Hpylori-associated gastritis in patients with both patterns of gastric carcinoma."' As of the time of publication of this article, it is safe to say that the exact role of H pvlori in causing gastric carcinoma is still not settled. Piesumably it is through its relation with multifocal atrophic gastritis that Hp~j1or-i and gastric cancer also are related. This is discussed in more detail in the discussion of multifocal atrophic gastritis.
Chronic Hpyloti infection with its induction of gastric lymphoid tissue has been implicated as a precursor of gastric lymphoma of the unique B-cell type that arises from mucosd-associated lymphoid tissue (MALT) ." In fact there have been attempts to treat some cases of the low grade variant with anti-Hpyloti regimens, and there has been some success, at least for the limited followup period." Nevertheless, the possibility of' treating a malignancy with antibiotics is exciting but also 
particularly those against parietal cells and intrinsic factor. The names "autoimmune gastritis" and "'autoimmune chronic atrophic gastritis" clearly are appropriate fi)r this combination.
It also goes by the name of "tvpe A chronic atrophic gastritis" and "diffuse corpus gastritis. "').I' This disease is most common in Scandinavia and Northern Europe.
Hdicohncttr @loti is not the only cause of chronic active gastritis. There are biopsy specimens that we encounter from time to time that have all the characteristics of H ,t$ori infection, yet have no Hrlicohncter, and no H Pylori are found by culture or by ancillary tests.
There is one other organism that is capable of causing a gastritis resembling H pylori gastritis. It is a tightly spiraled bacteria that has heen given the name of Cnstmpitillunr homir~i.s.5'~"4 This is a spirochete that has yet to be cultured. 1~ seems to be transmitted from household pets, dogs and cats, and it is a rare human pathogen. In one monumental study the investigators examined more than 15,000 antral biopsy specimens and found only Xl cases of Gc~strospidlum infection.
Two other smaller studies have found these bacteria in roughly the same frequency, with six cases in 1,650 patients in the first study and two cases in approximately 700 patients in the second study.'4 The inflammation induced by this bacterium is similar to that induced by 1 irlicobnctcl; hut the plasmacytosis, activity, and l\,mphoid hyperplasia all tend to be less intense.
How this gastritis evolves is not known, but there is some suggestion from a Swedish study that early in its evolution the lymphocytic and plasma cell inflammation is mostly in the deep mucosa rather than the superficial mucosa."
Possibly progression of this deep inflammation leads to destruction or atroph\, of the glands. In contrast, other investigators have implicated an early phase of superficial inflammation." Prcsumable deeper extension of this inflammation leads to loss of body glands. We have no idea why the tnetaplasias occur.
Patients with autoimmune chronic atrophic gastritis obviously produce no acid and no intrinsic tactor, both of'which are manufactured by parietal cells. They also have veIT little H pylori gastritis, suggesting that the organisms prefer an acid environment, although the\ attempt to bluffer themselves from that same acid.""." ' This type of diffuse body atrophic gastritis also occurs without the pernicious anemia and without autoantibodies. It is not clear if the anemia-and autoantibodynegative diffuse body gastritis is truly the same as the pernicious anemia-associated type or if it is an unusualI) difftise form of the multifocal or type B ,itt-ophic gastritis that is discussed next.
AUTOIMMUNE

CHRONIC ATROPHIC GASTRITK
We have known for years that pernicious anemia, ;I megdloblastic anemia caused by vitamin B-12 deficiency, is accompanied by a gastritis characterized by total or near total loss of oxyntic mucosa and replacement of that mucosa by elongated pits and metaplastic changes in the pits and in the remaining glands (Fig  "A) This risk is still small enough and the detection svstems, including upper endoscopy with biopsy and cytology, still expensive enough that there is no agreement about the need for a stuveillance program to detect the precancerous dysplasias and the C~I--cinemas in their very low stages.
To diagnose this gastritis with confidence the hiopsy specimens must come from areas normallv covered by body mucosa. there must bc no parietal cells or almost none, and there must be no comparable gastritis in the antral mucosa. The characteristic antiparictal cell and anti-intrinsic factor antibodies are helpful, as is the presence of the basal endocrine cell nodules. Finally, as is true for all the other gastritides, there is imperfect correlation between what the endoscopist sees and refers to as atrophic gastritis and what biopsies of such a stomach will yield. In general, endoscopic atrophy is represented by flat mucosa with few or no folds and a prominent vascularity, thought to be submucosal vessels more easily viewed due to an unusually thin mucosa. In truth, this appearance often does correlate with atrophic gastritis, but we have observed a number of cases of diffuse body atrophic gastritis in stomachs with normal folds or even exaggerated folds.
MULTIFOCAL ATROPHIC GASTRITIS
Quite frequently a biopsy specimen, especially one from the antral mucosa, has a small patch of intestinal metaplasia or even a single metaplastic pit. The question arises as to whether or not this is a forme fruste of atrophic gastritis. Clearly no one knows the answer with certainty, so the answer becomes a philosophical matter. If we assume that any intestinal metaplasia, no matter how small the focus, is the result of injury and if that patch of intestinal metaplasia is accompanied by diminution in the number of adjacent or underlying glands, then this patch should qualify as a focus of atrophic gastritis. Such patches occur in stomachs that have Hpyloti gastritis in the next microscopic field and others occur in otherwise normal mucosa. It is likely that they are manifestations of the most common gastric inflammation worldwide, other than H pyloti gastritis. This is a multifocal gastritis that has glandular atrophy and intestinal metaplasia as its histological components and that can involve any part of the stomach, but most commonly the antral and/or transitional mucosae of the antrum or antral-bodyjunction, especially along the lesser curvature at the incisura region (Fig 2B) .i8 This process has been designated as "multifocal atrophic gastritis" to emphasis its distribution or as "environmental gastritis" to suggest its epidemiological associations or as "type B chronic atrophic gastritis" to separate it from the type A atrophic gastritis that involves the body diffusely and spares the antrum."."' It is possible that every patch of intestinal metaplasia is a tiny manifestation of this multifocal disease. However, this disease, in spite of its worldwide dominance, is omitted from some chronic gastritis classifications, which appear to bury it in other categories that are likely to include H pylon' gastritis.""" This is the type of gastritis that seems to be the most common precursor of tubuleforming adenocarcinomas and its geographic distribution is the same as that of stomach cancer." In an analysis of precancerous lesions associated with 1,900 cases of early gastric cancer from Japan, atrophic gastritis of this type was found in almost 95% of the cases.59 It shares many histological features with Barrett's esophagus and diffuse body gastritis, including glandular atrophy; intestinal metaplasias of all varieties (both complete and incomplete); pyloric gland metaplasia when it involves body mucosa, lymphocytes and plasma cells in the lamina propria, and little, if any, neutrophilic activity.
The causes of this gastritis have not been clearly elucidated.
It is almost endemic in some parts of the world, such as in Japan, whereas it is much less prevalent in other places, such as in the United States. Obviously. this suggests that there are distinct environmental influences, such as diet, but the specific information is lacking, although excess salt and lack of certain fresh fruits and vegetables have been implicated." Recently H pylon' has been implicated as a potential cause. The evidence for this association is circumstantial, but it is In spite of its importance as the ma$or gastric cancer precursor worldwide, in most Western societies gastric carcinoma is no longer one of the important canc('rs numerically.
Thus, the finding of this gastritis in a biopsy specimen is no indication for placing any patient on a surveillance program to detect the dysplastic cancer precursors.
In contrast, in those societies in which gastric cancel-is a numerically important disease, screening programs for early detection are active, but such programs are not based on the finding of this gastritis because it is assumed that this gastritis is endemic in 'the population being screened.
CHEMICAL GASTROPATHIES, INCLUDING BILE REFL.UX
A co~nplex of histological changes in stomachs of patients who had gastroenteric anastomoses that were thought to be the result of reflux of bile into the stomach was describecl. These patients were likely to have bile reflux because the gastroenterostomy almost always had been performed for peptic ulcer disease and thus was accompanied by a distal gastrectomy, the purpose of which was to remove the antrum and all the gastrinproducimg cells. To remove the antrum completely the pylorus with its sphincter also was excised. The gastroenterostomy reattached the stomach to the small intestine, but Ithis attachment had no sphincter, so that bile could easily rcflllx into the gastric pouch.
The changes that were blamed on bile reflux included the following: (1) foveolar hyperplasia, (2) decreased mucin in the foveolar cells, (3) superficial edema, (4) increased smooth muscle fibers in the lamina propria, and (5) little inflammation (Fig 3) ."I In other words, this was not really a gastritis but a gastropathy. unless we regard the edema as an inflammatory exudate. All or any subset of these changes occur with regularity in stomachs that are anastotnosed to the small bowel, but the most common are the pit hyperplasia. the mucin depletion.
and the absence of intense inflammation.
Such changes occur not only in the gastric pouch but at the anastomotic site where they are often accompanied by prolapse changes that include pit distortion and even more smooth muscle in the lamina propria. In the stump one additional alteration is 11s~ ally present, namely, glandular atroph!,. This is independent of the reflux gastropathy and IS the result of' the antrertomy that removed the gastrin-producing cells, resulting in hypogastrinemia and subsequent atrophy of the body glands, especially the parietal cells that are dependent on normal gastrin secretion for their maintenance.
Bile reflux is best diagnosed either by the endoscopic finding of bile bathing the gastric mucosa or by a low luminal pH in the intact stomach that has proven normal acid secretion. Although the same histological changes occur in intact stomachs without gastroenterostomies, in such cases it appears that they are rarely caused by bile reflux but instead by other surface-damaging agents, such as NSAIDs.":! In hct, NSAIDs-related changes in the stomach have been described. consisting of the bile reflux complex plus a deep inflammation in the lamina propria that includes an infiltrate of eosinophils."' Thus, the changes of. pit hyperplasia and mucin depletion with little superficial inflammation form the basis for a group of gastric reactions to superficial injuries. The causes of many such injuries are considered to be chemical agents and the basic group of histological Non-steroidal anti-inflammatory drugs are emerging as the dominant cause of this reaction, although as with everything else in gastritis the data are conflicting. In one study there was no difference in the histological findings of chemical gastropathy among patients with either rheumatoid or osteoarthritis taking NSAIDs compared with a control group that did not take the drugs."" In contrast, in another study histological chemical gastropathy occurred about four times as often in NSAIDs users compared with those not taking the drugs:"
The recognition of this family of chemically induced abnormalities has greatly helped to simplify the classification of gastritis, although they are not always inflammations.
The changes of pit expansion, mucous depletion, and superficial edema are common to several diseases, including the gastritis of H @ori, some phases of the atrophic gastritides, the overhanging edges of peptic ulcers, the tips of hyperplastic polyps, and the tops of the folds in some of the giant fold diseases. Finding them in isolation, unassociated with bacteria, atrophy, metaplasias, ulcers, polyps, or big folds, should raise the possibility of chemical injuries as potential instigators.
LYMPHOCYTIC GASTRITIS
We now recognize a chronic gastritis with intense lymphocyte infiltration of the surface epithelium and the superficial pits, accompanied by lymphocytosis and plasmacytosis of the lamina propria (Fig 4) . This has been given the name of "lymphocytic gastritis."""," We can assume that this gastritis existed before it was named less than a decade ago. We probably placed it in some other category, such as "superficial gastritis." The lymphocytes are small, mature T cells. The infiltrated epithelium is disorganized, it has diminished mutin content, and the nuclei are stratified. These changes are virtuallv identical to those observed in the surface epithelium'in the primary intestinal malabsorption syndromes or sprues. In fact, some cases occur in patients with the sprues, both gluten-sensitive and -resistant.'"' At times the deeper pit epithelium also may be full of lymphocytes and there may be an accompanying pit hyperplasia. In one of the early reports it was thought that this peculiar inflammation was a response to a local antigen, possibly H p$ori, but this has never been proven."' When it accompanies one of the sprues we suspect that the gastric epithelium is being damaged by the same mechanisms that damage the surface epithelium in the small intestine.
However, other than this association with malabsorption we have no idea of its cause or causes.
Endoscopically, lymphocytic gastritis tends to produce a complex of abnormal patterns that have been grouped into the category of "varioliform gastritis." This includes thickened folds, often topped by small bumps or nodules with central depressions that may look like tiny erosions. However, there are no histological erosions, so this is still another example of poor endoscopic-histological correlation.
We have observed lymphocytic gastritis produce small endoscopic polyps, sometimes single, but other times as one of several polyps, the others usually being hyperplastic polyps. In fact, we have even observed gastric hyperplastic polyps in which the surface and superficial pit epithelia were infiltrated by lymphocytes in a pattern identical to lymphocytic gastritis. Lymphocytic gastritis usually does not produce symptoms. However, one type of giant fold disease, or hypertrophic gastropathy, is a diffuse form of lymphocytic gastritis associated with pit hyperplasia and accompanied by many of the clinical features of Menetrier's disease, including protein loss in about a third of the patients as well as nausea, vomiting, and abdominal pain."*
MISCELLANEOUS CHRONIC GASTRITIDES
There are many gastritides that do not differ significantly from similar inflammations elsewhere, includ- these are the changes described above in the unnamed focal lesions, which are found periodically in random gastric biopsy specimens in individuals without CL-ohn's disease. Nevertheless, a set of biopsy specimens that contains mllltiplta focal lcsions as described above should raise the possibilitv of Crohn's disease.
There is a f'ami,lv of granulomatous reactions ok granulomatous gastrltldes (Fig 5B) . Some* of' these arc part of a systemic granulomatoua disease, such as sarcoidosis, and some have been described as part of a systemic vasculitic syndrome or as an accompaniment of Whipple's disease. Others arc the gastric tnanifestations of focal gut diseases (usuallv (:rohn's disease), and in such cases the granulomas arc and solitaIT.7'." almosr always small Still others are not associated with an\ other disease and such cases have been designated as "isolated granulomatous gastritis." Finally, occasional granulomas occur next to ruptured pits. apparently reactions to extravasated mucin comparablt* with the ruptured crypt granulomas that are f'ound in thtt colon in many inflammatory diseases. .Allergic gastritis is usually pal-t of' a niorc extensive allergic gastroenteritis.7 '3 It mainlv affi.cts children, especially young children, who pre&Jlt with vomiting, diarrhea, weight loss, peripheral blood ~osinophilia. elevated serlml immunoglobulin E. and a histon. of'aller~ either in the patient, the family, or both. Biopsy specimens of the gastric antrum have a high yield of findings that include eosinophilia of the lamina propria that may be diffuse and intense as well as eosinophilic infiltration of the superficial and pit epithelium with accompanying epithelial damage and concurrent regeneration.
Weird, one-of-a-kind gastritides also occur, some of which even have published names. Thus, there is a single case report of "collagenous gastritis," characterized by a thick subepithelial band of collagen and a mild underlying inflammation.74 It is only fitting that we now have collagenous gastritis because collagenous colitis and collagenous sprue in the small bowel already exist. Collagenous esophagitis cannot be far behind!
ACUTE GASTRITIS
Although this article has concentrated on the chronic gastritides because they are by far the most common diagnostic problems and the processes that are currently studied most intensely, there are few truly acute inflammations of the gastric mucosa that deserve recognition.
When biopsies are performed on gastric mucosa they add to the diagnostic problems of the surgical pathologist.
Some of them may even be superimposed on the chronic gastritides and. as best as we can tell, they do not result in chronic sequellae, except for occasional chronic ulcers. Thus, they are not precursors of the chronic gastritides as far as we know. Acute H pylori gastritis was mentioned earlier, but this is not a biopsy issue because biopsies virtually never are performed on acute infectious gastritides, and there is very little published information about them or experience with them.
Many of the important, noninfectious acute inflammatory lesions of the stomach are small superficial erosions in which the epithelium of the surface and superficial pits and the superficial lamina propria are necrotic (Fig 6A) . This results in a superficial mucosal defect with no surface epithelium and a cell-poor granular lamina propria that may have a few extravasated erythrocytes in it. Considering the intensity of the necrosis there is remarkably little inflammation, usually no more than a few neutrophils at the junction between the viable and necrotic tissues. Intense epithelial regeneration usually is present at the same time with regenerating tubules often extending to the base of the mucosa as if the regenerative zone became so active that it encroached on the glandular compartment.
The total picture is a reaction to injury that looks much like acute ischemia or other surface necroses, such as occurs in the colon in the acute colitis of verotoxin-producing Escherichia coli. These days most such acute erosions are caused by ingestion of one of the NSAIDs, including aspirin. These erosive lesions develop as a result of deficient mucosal protective capabilities and may result from lowered prostaglandin synthesis by the gastric mucosa caused by the drugs.
Alcohol in actively drinking alcoholics has been historically implicated as another cause of such erosions, but although tiny superficial microscopic erosions may occur, alcohol seems to induce mainly a histological chemical gastropathy with reactive surface and pit epithelium.
However, in some alcoholics there are subepithelial hemorrhages in an edematous mucosa, both without much necrosis or inflammation.".7".7"
Occasional debilitated patients develop a diffusely necrotizing and hemorrhagic injury involving the superficial mucosa (Fig 6B) . This is possibly caused by ischemia in some cases, but the cause is often not known."-"
On occasion this can be life threatening. leading to uncontrollable hemorrhage requiring gastrectomy.
MULTIPLE COEXISTENT GASTRITIDES
If each of these types of gastritis is accepted as a separate entity and because many of them are common. it should not be surprising when more than one of thtm is foLtnd in a given stomach at the same time, so that a biopsy specimen contains multiple gastritides. As examples, we have observed antral biopsy specimens in which there was H l?ykori gastritis as well as patches of atrophic gastritis with intestinal metaplasia and loss of glands. We have even observed this combination complicated by an acute erosion in a patient treated with long-term NSAIDs. Sometimes patients with diffuse atrophic gastritis of the body, the type associated with pernicious anemia, also have antral biopsy specimens with multifocal atrophic gastritis. Thus, even the two types of atrophic gastritis exist in the same stomachs f&,m time to time. As mentioned earlier. it is unusual for H p$oti gastritis to be found in the antrum when autoimmune gastritis is present in the body.
CONCLUSlON
1s there a preferable, functional, completely useful, intellectually satisvi,ng classification of gastritis. especially chronic gastritis? Of course there is, but it is probably diffe,r-ent for different practitioners who work in different countries and in different practice settings. Any useful classification system probably depends on the types ~of'stomachs from which biopsy specimens are obtained, and this is likelv to be population-based. Any usetill classification system also depends on the needs of' the clinicians with whom we work because they are on the receiving end of our diagnoses. We pathologists must not work in a vacuum. The best approach to the classification of gastritis, especially that for the gamut of chronic gastritis, must consider what it is our clinical colleagues want us to tell them.
Furthermore, it is critical that we pathologists know whether it is even necessary and important to ever make a histological diagnosis of any kind of gastritis, because if it is not then the next issue becomes whether it is necessary or important ever to perform a biopsy on the stomach except to detect neoplasms or specific infections. There are facts about the different forms of gastritis. most of which have been presented earlier in this article, that may make most pathological diagnoses of gastritis (1) obsolete in the coming years: L'irtually every duodenal peptic ulcer is accompanied by H pylori antral gastritis. The only reason to perform a biopsy of the antrum in such cases is to determine if it is normal or if it has chemical gastropathy, so that the clinician cm be notified that the patient may be an NSAIDs user and the ulcer may be drugrather than bacterial-induced. It is a toss-up whether a given patient with non-U~CCI-dyspepsia will have H pylori gastritis, and some studies indicate that it does not matter if they do because approximately two thirds of all patients with this set of symptoms respond to antibacterial treatment. Every patient with pernicious anemia has type .A diffuse chronic atrophic gastritis of the body or corpus, so what is the point of biopsy except perhaps to chop out a few tiny carcinoid tu-
mars or screen for dysplasia; however, in neither situation is the biopsy for the gastritis. Virtually every patient with tubule-forming gastric adenocarcinoma has multifocal type R chronic atrophic gastritis and except for intellectual gratification or for purposes of epidemiological analysis we are not interested in the nontumorous mucosa.
(5) If we perform biopsies on enough patients with sprue we shall find that some of them have lymphocytic gastritis, but the real disease is in the proximal small bowel and not in the stomach.
(6) (7)
Perhaps every patient who is a long-term NSAIDs user will have microscopic gastric changes. However, their dyspeptic symptoms will tell us that they have drug toxicity and whether or not we find chemical gastropath) in the biopsy specimen will not matter. In patients with known Crohn's disease involving various parts of the small intestine or colon, careful examination of the stomach with many biopsy specimens will pick up focal inflammations in some patients, so why even perform a biopsy? The Crohn's disease that is the target of treatment is the large symptomatic segment, not the incidental focus that is onl) detected by screening. All of these statements are true and each is supported by extensive literature.
If what we know is abplied to the way we practice and if we accept that there are very few indications for histological diagnoses in the nontumorous stomachs, eventually we may put histological chronic gastritis to rest. In the meantime we pathologists shall continue to face the intellectual and professional challenges that require that we make only accurate diagnoses, and we shall continue the search for some satisfying classification scheme for the collection of pits, necks, glands, plasma cells, lymphoid nodules, neutrophils, eosinophils, distortion, atrophy, metaplasias, and epithelial damage that will allow us to place each histological gastritis into a predetermined niche.
APPENDIX
Ahbrf~ialions: NSAlDs, non-steroidal anti-inflammatory drugs: HE, hematoxylin-eosin; TNF, tumor necrosis f:dctor; MALT, mucosa-associated lymphoid tissue; ECL, entel-ochromaffinlike.
